As of 2026-03-16, the Relative Valuation of Landos Biopharma Inc (LABP) is (129.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.93 USD, the upside of Landos Biopharma Inc based on Relative Valuation is -665.7%.
The range of the Relative Valuation is (116.30) - (141.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.3x - 17.8x | 16.4x |
| Forward P/E multiples | 14.7x - 18.6x | 16.4x |
| Fair Price | (116.30) - (141.33) | (129.72) |
| Upside | -607.2% - -716.4% | -665.7% |
| Date | P/E |